DR
DeLuca Richard R.
Chief Executive Officer
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by DeLuca Richard R., Chief Executive Officer. Officer active across 1 company, notably Merck & Co., Inc.. Cumulatively, 22 filings have been recorded. Breakdown: 0 buy · 10 sells. Total volume traded: €14m. History available since 29 October 2021. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to DeLuca Richard R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
5,427 shares@ US$132.34960.0002% mcap2.1% of flowCommon StockSEC:0000310158-26-000219:2
11,099 shares@ US$131.61280.0005% mcap4.2% of flowCommon StockSEC:0000310158-26-000219:3
600 shares@ US$132.03670.0000% mcap0.2% of flowCommon StockSEC:0000310158-26-000219:4
20,784 shares@ US$130.43450.0009% mcap7.8% of flowCommon StockSEC:0000310158-26-000219:0
7,410 shares@ US$131.33130.0003% mcap2.8% of flowCommon StockSEC:0000310158-26-000219:1
805 shares@ US$131.02160.0000% mcap0.4% of flowCommon StockSEC:0000310158-26-000217:0
4,945 shares@ US$130.23120.0002% mcap2.2% of flowCommon StockSEC:0000310158-26-000217:1
300 shares@ US$131.02330.0000% mcap0.1% of flowCommon StockSEC:0000310158-26-000217:2
2,518 shares@ US$110.030.0001% mcap1.2% of flowCommon StockSEC:0000310158-26-000096:0
1,241 shares@ US$110.030.0000% mcap0.6% of flowCommon StockSEC:0000310158-26-000096:1
37,685 shares@ US$120.924116.0% of flowCommon StockSEC:0000310158-26-000032:0
12,264 shares@ US$107.404.6% of flowCommon StockSEC:0000310158-26-000012:0
25,438 shares@ US$97.9412.7% of flowCommon StockSEC:0001127602-25-002341:0
27,126 shares@ US$127.5117.1% of flowCommon StockSEC:0001127602-24-014269:0
23,296 shares@ US$119.4313.6% of flowCommon StockSEC:0001127602-24-002019:0
43,823 shares@ US$105.028622.9% of flowCommon StockSEC:0001127602-23-027077:0
66,163 shares@ US$62.0719.8% of flowCommon StockSEC:0001127602-23-014025:0
15,628 shares@ US$109.888.4% of flowCommon StockSEC:0001127602-23-002213:0
59,564 shares0Common StockSEC:0001127602-22-024626:0
15,966 shares@ US$73.514.3% of flowCommon StockSEC:0001127602-22-007002:0
29,782 shares0Common StockSEC:0001127602-21-028469:0
73,026 shares0Common StockSEC:0001127602-21-028165:0
About DeLuca Richard R.
DeLuca Richard R. is Directeur Général and EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (XNAS). He has 14 filings in total, and across the recent sample of 14 filings, there were no purchases and 8172268 EUR of sales, with filings dated from 2021-11-02 to 2026-05-01. The modal transaction nature is Levée d'options.